Update in treatment of uveitic macular edema

References

• LardenoyeCWvan KooijBRothovaAImpact of macular edema on visual acuity in uveitisOphthalmology200611381446144916877081
   PubMed Web of Science ®Google Scholar
• GritzDCWongIGIncidence and prevalence of uveitis in northern California; the Northern California Epidemiology of Uveitis StudyOphthalmology2004111349150015019324
   PubMed Web of Science ®Google Scholar
• SuhlerEBLloydMJChoiDRosenbaumJTAustinDFIncidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific NorthwestAm J Ophthalmol20081466890.e8896.e819027424
   PubMed Web of Science ®Google Scholar
• AcharyaNRThamVMEsterbergEIncidence and prevalence of uveitis: results from the Pacific ocular inflammation studyJAMA Ophthalmol2013131111405141224008391
   PubMed Web of Science ®Google Scholar
• MiserocchiEFogliatoGModoratiGBandelloFReview on the worldwide epidemiology of uveitisEur J Ophthalmol201323570571723661536
   PubMed Web of Science ®Google Scholar
• de SmetMDTaylorSRBodaghiBUnderstanding uveitis: the impact of research on visual outcomesProg Retin Eye Res201130645247021807112
   PubMed Web of Science ®Google Scholar
• FardeauCChampionEMassambaNLehoangPOEdème maculaire Au cours des uvéites [Uveitic macular edema]J Fr Ophtalmol20153817481 French25547721
   PubMed Web of Science ®Google Scholar
• RothovaASuttorp-van SchultenMSAFrits TreffersWKijlstraACauses and frequency of blindness in patients with intraocular inflammatory diseaseBr J Ophthalmol19968043323368703885
   PubMed Web of Science ®Google Scholar
• Suttorp-SchultenMSARothovaAThe possible impact of uveitis in blindness: a literature surveyBr J Ophthalmol19968098448488962842
   PubMed Web of Science ®Google Scholar
• RothovaAInflammatory cystoid macular edemaCurr Opin Ophthalmol200718648749218163001
   PubMed Web of Science ®Google Scholar
• FardeauCChampionEMassambaNLehoangPUveitic macular edemaEye (Lond)201630101277129227256304
   PubMed Web of Science ®Google Scholar
• DurraniOMTehraniNNMarrJEMoradiPStavrouPMurrayPIDuration, and causes of visual loss in uveitisBr J Ophthalmol20048891159116215317708
   PubMed Web of Science ®Google Scholar
• GassJDNortonEWCystoid macular edema and papilledema following cataract extraction: a fluorescein fundoscopic and angiographic studyArch Ophthalmol19667656466615955948
   PubMedGoogle Scholar
• StaurenghiGde PoloLPellegriniMMacular edema. Diagnosis and detectionDev Ophthalmol201047274820703042
   PubMedGoogle Scholar
• Ossewaarde-van NorelARothovaAImaging methods for inflammatory macular edemaInt Ophthalmol Clin2012524556622954929
   PubMedGoogle Scholar
• SkondraDHunterRPapakostasTDVavvasDGNear infrared autofluorescence imaging of retinal diseasesSemin Ophthalmol2012275–620220823163277
   PubMed Web of Science ®Google Scholar
• KempenJHSugarEAJaffeGJFluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edemaOphthalmology201312091852185923706700
   PubMed Web of Science ®Google Scholar
• KozakIMorrisonVLClarkTMDiscrepancy between fluorescein angiography and optical coherence tomography in detection of macular diseaseRetina200828453854418398354
   PubMed Web of Science ®Google Scholar
• HoweLStanfordMGrahamEMarshallJIndocyanine green angiography in inflammatory eye diseaseEye199812576176710070505
   PubMed Web of Science ®Google Scholar
• RoeselMHeinzCDietzelMSpitalGHenschelAHeiligenhausAFundus autofluorescence and spectral domain optical coherence tomography in uveitic macular edemaGraefes Arch Clin Exp Ophthalmol2009247121685168919669782
   PubMed Web of Science ®Google Scholar
• RoeselMHeimesBHeinzCHenschelASpitalGHeiligenhausAComparison of retinal thickness and fundus-related microperimetry with visual acuity in uveitic macular oedemaActa Ophthalmol201189653353720003108
   PubMed Web of Science ®Google Scholar
• KempenJHAltaweelMMHolbrookJTJabsDALouisTASugarEAThorneJEMulticenter Uveitis Steroid Treatment (MUST) Trial Research Group, Writing CommitteeRandomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: The Multicenter Uveitis Steroid Treatment TrialOphthalmology2011118101916192621840602
   PubMed Web of Science ®Google Scholar
• SenHNVitaleSGangaputraSSPeriocular corticosteroid injections in uveitis: effects and complicationsOphthalmology2014121112275228625017415
   PubMed Web of Science ®Google Scholar
• LowderCBelfortRLightmanSDexamethasone intravitreal implant for noninfectious intermediate or posterior uveitisArch Ophthalmol2011129554510
   Google Scholar
• SheppardJDToyosMMKempenJHKaurPFosterCSDifluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized studyInvestig Ophthalmol Vis Sci20145552993300224677110
   PubMed Web of Science ®Google Scholar
• TajikaTWakiMTsuzukiMKidaTSakakiHPharmacokinetic features of difluprednate ophthalmic emulsion in rabbits as determined by glucocorticoid receptor-binding bioassayJ Ocul Pharmacol Ther2011271293421182429
   PubMed Web of Science ®Google Scholar
• SymesRJForooghianFTopical difluprednate monotherapy for uveitic macular edemaCan J Ophthalmol2016511474926874159
   PubMed Web of Science ®Google Scholar
• SchallhornJMNiemeyerKMBrowneENChhetriPAcharyaNRDifluprednate for the treatment of uveitic cystoid macular edemaAm J Ophthalmol2018191142229580977
   PubMed Web of Science ®Google Scholar
• SlabaughMAHerlihyEOngchinSvan GelderRNEfficacy and potential complications of difluprednate use for pediatric uveitisAm J Ophthalmol2012153593293822265149
   PubMed Web of Science ®Google Scholar
• FeilerDLSrivastavaSKPichiFBenaJLowderCYResolution of noninfectious uveitic cystoid macular edema with topical difluprednateRetina201737584485027529841
   PubMed Web of Science ®Google Scholar
• JermakCMDellacroceJTHeffezJPeymanGATriamcinolone acetonide in ocular therapeuticsSurv Ophthalmol200752550352217719372
   PubMed Web of Science ®Google Scholar
• LederHAJabsDAGalorADunnJPThorneJEPeriocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitisAm J Ophthalmol2011152344144821652023
   PubMed Web of Science ®Google Scholar
• IwaoKInataniMKawajiTKogaTMawatariYTaniharaHFrequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injectionJ Glaucoma200716225125617473740
   PubMed Web of Science ®Google Scholar
• FerrantePRamseyABunceCLightmanSClinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitisClin Exp Ophthalmol200432656356815575824
   PubMed Web of Science ®Google Scholar
• KokHLauCMaycockNMcCluskeyPLightmanSOutcome of intravitreal triamcinolone in uveitisOphthalmology2005112111916.e11916.e716171868
   PubMed Web of Science ®Google Scholar
• AndroudiSLetkoEMeniconiMPapadakiTAhmedMFosterCSSafety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edemaOcul Immunol Inflamm2005132–320521216019680
   PubMed Web of Science ®Google Scholar
• AngunawelaRIHeatleyCJWilliamsonTHIntravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: long-term management and outcomeActa Ophthalmol Scand200583559559916187999
   PubMedGoogle Scholar
• YoungSLarkinGBranleyMLightmanSSafety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitisClin Exp Ophthalmol20012912611272779
   PubMed Web of Science ®Google Scholar
• SallamAComerRMChangJHShort-term safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema in childrenArch Ophthalmol2008126220018268210
   PubMedGoogle Scholar
• SallamATaylorSRJHabot-WilnerZRepeat intravitreal triamcinolone acetonide injections in uveitic macular oedemaActa Ophthalmol2012904e323e32521914149
   PubMed Web of Science ®Google Scholar
• ShinJYYuHGIntravitreal triamcinolone injection for uveitic macular edema: a randomized clinical studyOcul Immunol Inflamm201523643043626308286
   PubMed Web of Science ®Google Scholar
• RoeselMGutfleischMHeinzCHeimesBZurek-ImhoffBHeiligenhausAIntravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative studyOphthalmic Res2009422818619478546
   PubMed Web of Science ®Google Scholar
• AdánAPelegrínLReyADexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patientsRetina20133371435144023514796
   PubMed Web of Science ®Google Scholar
• BezatisASpitalGHöhnFFunctional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up – the solo studyActa Ophthalmol2013915e340e34723638803
   PubMed Web of Science ®Google Scholar
• TsangACVirgiliGAbtahiMGottliebCCIntravitreal dexamethasone implant for the treatment of macular edema in chronic noninfectious uveitisOcul Immunol Inflamm201725568569227191685
   PubMed Web of Science ®Google Scholar
• CaoJHMulvahillMZhangLJoondephBCDaceyMSDexamethasone intravitreal implant in the treatment of persistent uveitic macular edema in the absence of active inflammationOphthalmology2014121101871187624907061
   PubMed Web of Science ®Google Scholar
• LamWCAlbianiDAYoganathanPReal-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the chrome studyClin Ophthalmol201591255126826203215
   PubMed Web of Science ®Google Scholar
• ChinHSParkTSMoonYSOhJHDifference in clearance of intra-vitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyesRetina200525555656016077349
   PubMed Web of Science ®Google Scholar
• Chang-LinJEBurkeJAPengQPharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyesInvestig Ophthalmol Vis Sci20115274605460921421864
   PubMed Web of Science ®Google Scholar
• PavesioCZierhutMBairiKComstockTLUsnerDWFluocinolone Acetonide Study GroupEvaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitisOphthalmology2010117356757520079922
   PubMed Web of Science ®Google Scholar
• CallananDGJaffeGJMartinDFPearsonPAComstockTLTreatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial resultsArch Ophthalmol200812691191120118779477
   PubMedGoogle Scholar
• JaffeGJMartinDCallananDFluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical studyOphthalmology20061136102016690128
   PubMed Web of Science ®Google Scholar
• Tomkins-NetzerOLightmanSDryeLMulticenter Uveitis Steroid Treatment Trial Research GroupOutcome of treatment of uveitic macular edema: The Multicenter Uveitis Steroid Treatment Trial 2-year resultsOphthalmology2015122112351235926359188
   PubMed Web of Science ®Google Scholar
• FonollosaALlorençVArtarazJSafety and efficacy of intravitreal dexamethasone implants in the management of macular edema secondary to infectious uveitisRetina20163691778178527183031
   PubMed Web of Science ®Google Scholar
• AgarwalAHandaSAggarwalKThe role of dexamethasone implant in the management of tubercular uveitisOcul Immunol Inflamm201826688489229190170
   PubMed Web of Science ®Google Scholar
• JabsDARosenbaumJTFosterCSGuidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panelAm J Ophthalmol2000130449251311024423
   PubMed Web of Science ®Google Scholar
• PetrushkinHRogersDPavesioCThe use of topical non-steroidal anti-inflammatory drugs for uveitic cystoid macular edemaOcul Immunol Inflamm201826579579728080174
   PubMed Web of Science ®Google Scholar
• RadwanAEArcinueCAYangPArtornsombudhPAbu Al-FadlEMFosterCSBromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edemaGraefes Arch Clin Exp Ophthalmol201325171801180623519884
   PubMed Web of Science ®Google Scholar
• AllegriPMurialdoUPeriSRandomized, double-blind, placebo-controlled clinical trial on the efficacy of 0.5% indomethacin eye drops in uveitic macular edemaInvest Ophthalmol Vis Sci2014553146310
   Web of Science ®Google Scholar
• SoheilianMEskandariARamezaniARabbanikhahZSoheilianRA pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edemaOcul Immunol Inflamm201321212412923697857
   PubMed Web of Science ®Google Scholar
• KianersiFRezaeian-RamshehAPouraziziMKianersiHIntravitreal diclofenac for treatment of refractory uveitis-associated cystoid macular oedema: a before and after clinical studyActa Ophthalmol2018963e355e36029369543
   PubMed Web of Science ®Google Scholar
• EsmaeilpourNFRabbanikhahZSoheilianRSoheilianMIntravitreal diclofenac for refractory uveitic cystoid macular edemaJ Ophthalmic Vis Res201381475223825712
   PubMedGoogle Scholar
• CoxSNHayEBirdACTreatment of chronic macular edema with acetazolamideArch Ophthalmol19881069119011953415543
   PubMedGoogle Scholar
• PeppleKLNguyenMHPakzad-VaeziKResponse of inflammatory cystoid macular edema to treatment using oral acetazolamideRetina (Philadelphia, Pa) Epub2018116
   PubMed Web of Science ®Google Scholar
• SchillingHHeiligenhausALaubeTBornfeldNJurkliesBLong-term effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammationRetina200525218218815689809
   PubMed Web of Science ®Google Scholar
• FarberMDLamSTesslerHHJenningsTJCrossARusinMMReduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover studyBr J Ophthalmol1994781478110697
   PubMed Web of Science ®Google Scholar
• WhitcupSMCsakyKGPodgorMJA randomized, masked, crossover trial of acetazolamide for cystoid macular edema in patients with uveitisOphthalmology19961037105410638684794
   PubMed Web of Science ®Google Scholar
• BaconPASalmonMModes of action of second-line agentsScand J Rheumatol198716Suppl 6417243589587
   PubMed Web of Science ®Google Scholar
• PatoEMuñoz-FernándezSFranciscoFSystematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitisSemin Arthritis Rheum201140431432320656330
   PubMed Web of Science ®Google Scholar
• MéridaSPalaciosENaveaABosch-MorellFNew immunosuppressive therapies in uveitis treatmentInt J Mol Sci2015168187781879526270662
   PubMed Web of Science ®Google Scholar
• PachecoPATaylorSRCuchacovichMTDiazGVAzathioprine in the management of autoimmune uveitisOcul Immunol Inflamm200816416116518716951
   PubMed Web of Science ®Google Scholar
• ThorneJEJabsDAPetersGBHairDDunnJPKempenJHBird-shot retinochoroidopathy: ocular complications and visual impairmentAm J Ophthalmol20051401455116038650
   PubMed Web of Science ®Google Scholar
• GangaputraSNewcombCWLiesegangTLMethotrexate for ocular inflammatory diseasesOphthalmology2009116112188219819748676
   PubMed Web of Science ®Google Scholar
• TaylorSRHabot-WilnerZPachecoPLightmanSLIntraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edemaOphthalmology2009116479780119344827
   PubMed Web of Science ®Google Scholar
• TaylorSRJBankerASchlaenAIntraocular methotrexate can induce extended remission in some patients in noninfectious uveitisRetina201333102149215423615343
   PubMed Web of Science ®Google Scholar
• ThorneJEJabsDAQaziFANguyenQDKempenJHDunnJPMycophenolate mofetil therapy for inflammatory eye diseaseOphthalmology200511281472147716061096
   PubMed Web of Science ®Google Scholar
• GoldbergNRLyuTMoshierEGodboldJJabsDASuccess with single-agent immunosuppression for multifocal choroidopathiesAm J Ophthalmol201415861310131725194229
   PubMed Web of Science ®Google Scholar
• DoychevaDJägleHZierhutMMycophenolic acid in the treatment of birdshot chorioretinopathy: long-term follow-upBr J Ophthalmol2015991879125061107
   PubMed Web of Science ®Google Scholar
• NeriPMariottiCCiminoLMercantiLGiovanniniALong-term control of cystoid macular oedema in noninfectious uveitis with myco-phenolate mofetilInt Ophthalmol200829312713318297240
   PubMedGoogle Scholar
• DoychevaDZierhutMBlumenstockGStuebigerNDeuterCMycophenolate mofetil in the therapy of uveitic macular edema – long-term resultsOcul Immunol Inflamm201220320321122489750
   PubMed Web of Science ®Google Scholar
• MathewsDMathewsJJonesNPLow-dose cyclosporine treatment for sight-threatening uveitis: efficacy, toxicity, and toleranceIndian J Ophthalmol20105815520029146
   PubMed Web of Science ®Google Scholar
• KaçmazROKempenJHNewcombCCyclosporine for ocular inflammatory diseasesOphthalmology2010117357658420031223
   PubMed Web of Science ®Google Scholar
• NussenblattRBPalestineAGChanCCCyclosporin a therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agentsAm J Ophthalmol19839632752826614105
   PubMed Web of Science ®Google Scholar
• NussenblattRBPalestineAGChanCCStevensGMellowSDGreenSBRandomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitisAm J Ophthalmol199111221381461867297
   PubMed Web of Science ®Google Scholar
• JeonSLeeWKJungYChanges in the intraocular cytokine levels after intravitreal bevacizumab in uveitic macular edemaOcul Immunol Inflamm201220536036423030355
   PubMed Web of Science ®Google Scholar
• MurphyCCGreinerKPlskovaJCyclosporine vs tacrolimus therapy for posterior and intermediate uveitisArch Ophthalmol2005123563464115883282
   PubMedGoogle Scholar
• HoganACMcAvoyCEDickADLeeRWLong-term efficacy and tolerance of tacrolimus for the treatment of uveitisOphthalmology200711451000100617467532
   PubMed Web of Science ®Google Scholar
• AgarwalARajagopalanNHassanMSirolimus for retinal and uveitic diseasesDev Ophthalmol20165527628126501229
   PubMedGoogle Scholar
• ShanmuganathanVACaselyEMRajDThe efficacy of sirolimus in the treatment of patients with refractory uveitisBr J Ophthalmol200589666666915923497
   PubMed Web of Science ®Google Scholar
• PhillipsBNWroblewskiKJA retrospective review of oral low-dose sirolimus (rapamycin) for the treatment of active uveitisJ Ophthalmic Inflamm Infect201011293421475659
   PubMedGoogle Scholar
• NguyenQDIbrahimMAWattersAOcular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE StudyJ Ophthalmic Inflamm Infect2013313223514595
   PubMedGoogle Scholar
• NguyenQDSadiqMASolimanMKAgarwalAdoDVSepahYJThe effect of different dosing schedules of intravitreal sirolimus, a mammalian target of rapamycin (mTOR) inhibitor, in the treatment of non-infectious uveitis (an American Ophthalmological Society thesis)Trans Am Ophthalmol Soc2016114
   PubMedGoogle Scholar
• BuhaescuIIzzedineHCovicASirolimus – challenging current perspectivesTher Drug Monit200628557758417038868
   PubMed Web of Science ®Google Scholar
• GilliesMCSuTInterferon-alpha 2B enhances barrier function of bovine retinal microvascular endothelium in vitroMicrovasc Res19954932772887643749
   PubMed Web of Science ®Google Scholar
• TheofilopoulosANBaccalaRBeutlerBKonoDHType I interferons (alpha/beta) in immunity and autoimmunityAnnu Rev Immunol20052330733615771573
   PubMed Web of Science ®Google Scholar
• KötterIEcksteinAKStübigerNZierhutMTreatment of ocular symptoms of Behçet’s disease with interferon alpha 2A: a pilot studyBr J Ophthalmol19988254884949713053
   PubMed Web of Science ®Google Scholar
• FeronEJRothovaAvan HagenPMBaarsmaGSSuttorp-SchultenMSInterferon-alpha 2b for refractory ocular Behçet’s diseaseLancet199434389101428
   PubMed Web of Science ®Google Scholar
• KötterIZierhutMEcksteinAKHuman recombinant interferon alfa-2a for the treatment of Behçet’s disease with sight threatening posterior or panuveitisBr J Ophthalmol200387442343112642304
   PubMed Web of Science ®Google Scholar
• DeuterCMEKoetterINAGuenaydinIStuebigerNZierhutMInterferon alfa-2a: a new treatment option for long lasting refractory cystoid macular edema in uveitis? A pilot studyRetina200626778679116963852
   PubMed Web of Science ®Google Scholar
• BodaghiBGendronGWechslerBEfficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patientsBr J Ophthalmol20079133533917050581
   PubMed Web of Science ®Google Scholar
• DeuterCMKötterIGünaydinIStübigerNDoychevaDGZierhutMEfficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitisBr J Ophthalmol200993790691319321469
   PubMed Web of Science ®Google Scholar
• FardeauCSimonARoddeBInterferon-alpha2a and systemic corticosteroid in monotherapy in chronic uveitis: results of the randomized controlled BIRDFERON studyAm J Ophthalmol201717718219428315319
   PubMed Web of Science ®Google Scholar
• DiwoEGueudryJSaadounDWeschlerBLehoangPBodaghiBLong-term efficacy of interferon in severe uveitis associated with Behçet diseaseOcul Immunol Inflamm2017251768427541620
   PubMed Web of Science ®Google Scholar
• PlskovaJGreinerKForresterJVInterferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitisAm J Ophthalmol20071441556117601428
   PubMed Web of Science ®Google Scholar
• ButlerNJSuhlerEBRosenbaumJTInterferon alpha 2b in the treatment of uveitic cystoid macular edemaOcul Immunol Inflamm2012202869022409560
   PubMed Web of Science ®Google Scholar
• MackensenFJakobESpringerCInterferon versus methotrexate in intermediate uveitis with macular edema: results of a randomized controlled clinical trialAm J Ophthalmol2013156347848623786783
   PubMed Web of Science ®Google Scholar
• MackensenFMaxRBeckerMDInterferons and their potential in the treatment of ocular inflammationClin Ophthalmol2009355919898628
   PubMedGoogle Scholar
• DickADForresterJVLiversidgeJCopeAPThe role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU)Prog Retin Eye Res200423661763715388077
   PubMed Web of Science ®Google Scholar
• Díaz-LlopisMSalomDGarcia-de-VicuñaCTreatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patientsOphthalmology201211981575158122525047
   PubMed Web of Science ®Google Scholar
• DobnerBCMaxRBeckerMDA three-centre experience with adalimumab for the treatment of non-infectious uveitisBr J Ophthalmol201297213413823212204
   PubMed Web of Science ®Google Scholar
• Al RashidiSAl FawazAKangaveDAbu El-AsrarAMLong-term clinical outcomes in patients with refractory uveitis associated with Behçet disease treated with infliximabOcul Immunol Inflamm201321646847423734940
   PubMed Web of Science ®Google Scholar
• Schaap-FoglerMAmerRFrilingRPrielEKramerMAnti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitisGraefes Arch Clin Exp Ophthalmol2014252463364024366669
   PubMed Web of Science ®Google Scholar
• MarkomichelakisNNTheodossiadisPGPanteliaEPapaefthimiouSTheodossiadisGPSfikakisPPInfliximab for chronic cystoid macular edema associated with uveitisAm J Ophthalmol2004138464865015488796
   PubMed Web of Science ®Google Scholar
• MalekiASahawnehHFMaLMeeseHHeYFosterCSInfliximab therapy in patients with noninfectious intermediate uveitis resistant to conventional immunomodulatory therapyRetina201737583684327681002
   PubMed Web of Science ®Google Scholar
• MarkomichelakisNDelichaEMasselosSFragiadakiKKaklamanisPSfikakisPPA single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behcet’s disease: a comparative 4-week studyRheumatology201150359359721097877
   PubMed Web of Science ®Google Scholar
• FarvardinMAfaridMShahrzadSLong-term effects of intravitreal infliximab for treatment of sight-threatening chronic noninfectious uveitisJ Ocul Pharmacol Ther201228662863122794354
   PubMed Web of Science ®Google Scholar
• AndroudiSTsironiEKalogeropoulosCTheodoridouABrazitikosPIntravitreal adalimumab for refractory uveitis-related macular edemaOphthalmology201011781612161620378179
   PubMed Web of Science ®Google Scholar
• HamamRNBarikianAWAntoniosRSIntravitreal adalimumab in active noninfectious uveitis: a pilot studyOcul Immunol Inflamm201624331932625549063
   PubMed Web of Science ®Google Scholar
• ImrieFRDickADBiologics in the treatment of uveitisCurr Opin Ophthalmol200718648148618163000
   PubMed Web of Science ®Google Scholar
• BamforthSDLightmanSLGreenwoodJUltrastructural analysis of interleukin-1 beta-induced leukocyte recruitment to the rat retinaInvest Ophthalmol Vis Sci199738125359008627
   PubMed Web of Science ®Google Scholar
• Tugal-TutkunIPavesioCde CordoueABernard-PoenaruOGülAUse of gevokizumab in patients with Behçet’s disease uveitis: an international, randomized, double-masked, placebo-controlled study and open-label extension studyOcular Immunol Inflamm201826710231033
   PubMed Web of Science ®Google Scholar
• FabianiCVitaleAEmmiGEfficacy and safety of adalimumab in Behçet’s disease-related uveitis: a multicenter retrospective observational studyClin Rheumatol201636118318927853889
   PubMed Web of Science ®Google Scholar
• TanakaTKishimotoTTargeting interleukin-6: all the way to treat autoimmune and inflammatory diseasesInt J Biol Sci2012891227123623136551
   PubMed Web of Science ®Google Scholar
• DeuterCMEZierhutMIgney-OertelATocilizumab in uveitic macular edema refractory to previous immunomodulatory treatmentOcul Immunol Inflamm201725221522026731514
   PubMed Web of Science ®Google Scholar
• MesquidaMMolinsBLlorençVTwenty-four month follow-up of tocilizumab therapy for refractory uveitis-related macular edemaRetina20183871361137028520640
   PubMed Web of Science ®Google Scholar
• AdánAMesquidaMLlorençVTocilizumab treatment for refractory uveitis-related cystoid macular edemaGraefe’s Arch Clin Exp Ophthalmol2013251112627263223893042
   PubMed Web of Science ®Google Scholar
• Calvo-RíoVSantos-GómezMCalvoIAnti-interleukin-6 receptor tocilizumab for severe juvenile idiopathic arthritis-associated uveitis refractory to anti-tumor necrosis factor therapy: a multicenter study of twenty-five patientsArthritis Rheumatol201769366867527696756
   PubMed Web of Science ®Google Scholar
• NussenblattRBPetersonJSFosterCSInitial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case seriesOphthalmology2005112576477015878055
   PubMed Web of Science ®Google Scholar
• PapaliodisGNChuDFosterCSTreatment of ocular inflammatory disorders with daclizumabOphthalmology2003110478678912689903
   PubMed Web of Science ®Google Scholar
• BhatPCastañeda-CervantesRADoctorPPCsFFosterCSIntravenous daclizumab for recalcitrant ocular inflammatory diseaseGraefe’s Arch Clin Exp Ophthalmol2009247568768919198869
   PubMed Web of Science ®Google Scholar
• WroblewskiKSenHNYehSLong-term daclizumab therapy for the treatment of noninfectious ocular inflammatory diseaseCan J Ophthalmol201146432232821816251
   PubMed Web of Science ®Google Scholar
• SobrinLHuangJJChristenWKafkalaCChoopongPFosterCSDaclizumab for treatment of birdshot chorioretinopathyArch Ophthalmol2008126218618268208
   PubMed Web of Science ®Google Scholar
• BuggageRRLevy-ClarkeGSenHNA double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet’s diseaseOcul Immunol Inflamm2007152637017558830
   PubMed Web of Science ®Google Scholar
• ComynOLightmanSLHykinPGCorticosteroid intravitreal implants vs. ranibizumab for the treatment of vitreoretinal diseaseCurr Opin Ophthalmol201324324825423518614
   PubMed Web of Science ®Google Scholar
• BaeJHLeeCSLeeSCEfficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edemaRetina201131111111820856170
   PubMed Web of Science ®Google Scholar
• Cervantes-CastañedaRAGiuliariGPGallagherMJIntravitreal bevacizumab in refractory uveitic macular edema: one-year follow-upEur J Ophthalmol200919462262919551679
   PubMed Web of Science ®Google Scholar
• WeissKSteinbruggerIWegerMIntravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumabEye20092391812181819169227
   PubMed Web of Science ®Google Scholar
• KozakIShoughySSStoneDUIntravitreal antiangiogenic therapy of uveitic macular edema: a reviewJ Ocul Pharmacol Ther201733423523928165851
   PubMed Web of Science ®Google Scholar
• PerosaFFavoinoECaragnanoMAPreteMDammaccoFCD20: a target antigen for immunotherapy of autoimmune diseasesAutoimmun Rev20054852653116214090
   PubMed Web of Science ®Google Scholar
• DavatchiFShamsHRezaipoorMRituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study)Int J Rheum Dis201013324625220704622
   PubMed Web of Science ®Google Scholar
• TappeinerCHeinzCSpeckerCHeiligenhausARituximab as a treatment option for refractory endogenous anterior uveitisOphthalmic Res200739318418617534119
   PubMed Web of Science ®Google Scholar
• BussoneGKaswinGde MenthonMDelairEBrézinAPGuillevinLMacular oedema following rituximab infusion in two patients with Wegener’s granulomatosisClin Exp Rheumatol2010281 Suppl 57909220412711
   PubMed Web of Science ®Google Scholar
• GilcaMMerrillPTCystoid macular edema secondary to rituximabRetin Cases Brief Rep Epub201736
   Google Scholar
• SalliotCDougadosMGossecLRisk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trialsAnn Rheum Dis2009681253218203761
   PubMed Web of Science ®Google Scholar
• MiserocchiEModoratiGRituximab for noninfectious uveitisDev Ophthalmol2012519810922517208
   PubMedGoogle Scholar
• FaiaLJNida SenHLiZTreatment of inflammatory macular edema with humanized anti-CD11a antibody therapyInvestig Ophthalmol Vis Sci20115296919692421498606
   PubMed Web of Science ®Google Scholar
• GolanSLoewensteinASurgical treatment for macular edemaSemin Ophthalmol201429424225624409947
   PubMed Web of Science ®Google Scholar
• GutfleischMSpitalGMingelsAPauleikhoffDLommatzschAHeiligenhausAPars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitationsBr J Ophthalmol200791334534817005547
   PubMed Web of Science ®Google Scholar
• TranosPScottRZambarakjiHThe effect of pars plana vitrectomy on cystoid macular oedema associated with chronic uveitis: a randomised, controlled pilot studyBr J Ophthalmol20069091107111016723360
   PubMed Web of Science ®Google Scholar
• HenryCRBeckerMDYangYDavisJLPars plana vitrectomy for the treatment of uveitisAm J Ophthalmol201819014214929601822
   PubMed Web of Science ®Google Scholar
• RadetzkySWalterPFauserSKoizumiKKirchhofBVisual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membraneGraefe’s Arch Clin Exp Ophthalmol2004242427327815042375
   PubMed Web of Science ®Google Scholar
• MuhayaMCalderVLTowlerHMJollyGMcLauchlanMLightmanSCharacterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in manClin Exp Immunol1999116341041410361227
   PubMed Web of Science ®Google Scholar
• LiversidgeJDickAChengYFScottGBForresterJVRetinal antigen specific lymphocytes, TCR-gamma delta T cells and CD5+ B cells cultured from the vitreous in acute sympathetic ophthalmitisAutoimmunity19931542572667511004
   PubMed Web of Science ®Google Scholar
• TranosPGTsaousisKTVakalisANAsteriadesSPavesioCELong-term follow-up of inflammatory cystoid macular edemaRetina20123281624162822481481
   PubMed Web of Science ®Google Scholar
• BaughmanRPBarneyJBO’HareLLowerEEA retrospective pilot study examining the use of Acthar gel in sarcoidosis patientsRespir Med2016110667226626451
   PubMed Web of Science ®Google Scholar
• TaylorPCAbdul AzeezMKiriakidisSFilgotinib for the treatment of rheumatoid arthritisExpert Opin Investig Drugs2017261011811187
   PubMed Web of Science ®Google Scholar
• FeaganBGSandbornWJGasinkCUNITI–IM-UNITI Study GroupUstekinumab as induction and maintenance therapy for Crohn’s diseaseN Engl J Med2016375201946196027959607
   PubMed Web of Science ®Google Scholar
• López-FerrerALaizAPuigLThe safety of ustekinumab for the treatment of psoriatic arthritisExp Opin Drug Saf2017166733742
   PubMed Web of Science ®Google Scholar
• The Cleveland Clinic, MallinckrodtOcular Sarcoidosis Open Label Trial of ACTHAR Gel Available from: https://clinicaltrials.gov/ct2/show/NCT02725177?term=macular+edema&cond=Uveitis&rank=58. ClinicalTrials.gov Identifier: NCT02725177Accessed 15 October 2018
   Google Scholar
• John HuangMD(ACTH) for the Treatment of Sarcoid Uveitis (ACTH) Available from: https://clinicaltrials.gov/ct2/show/NCT03473964?term=macular+edema&cond=Uveitis&rank=40. ClinicalTrials.gov Identifier: NCT03473964Accessed 15 October 2018
   Google Scholar
• Gilead SciencesEfficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis (Humboldt) Available from: https://clinicaltrials.gov/ct2/show/NCT03207815?term=macular+edema&cond=Uveitis&rank=45. ClinicalTrials.gov Identifier: NCT03207815Accessed 15 October 2018
   Google Scholar
• National Eye Institute (NEI)Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study) Available from: https://clinicaltrials.gov/ct2/show/NCT02911116?term=ustekinumab&cond=uveitis&rank=1. ClinicalTrials.gov Identifier: NCT02911116Accessed 15 October 2018
   Google Scholar